Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-&kappa;B activation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

669

HTML

7032

Figures (1-4)

257

Tables (1-4)

266

Sum=8224

Jun 21, 2006 (publication date) through Mar 7, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jun 21, 2006; 12(23): 3729-3735
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3729

Table 1 Bacterial strains used in this study

Strain oroligonucleotides	Relevant characteristics	Source orPCR product
E. coli
TG1	Cloning host	DSMZ¹
D2241	Non-pathogenic intestinal isolate, control	NCC²
Bifidobacterium
NCC362	B. lactis, type strain	NCC²
NCC2705	B. longum, type strain	NCC²
NCC251	B. adolescentis, type strain	NCC²
NCC189	B. bifidum	NCC²
S16	B. bifidum, intestinal isolate from a breast-fed infant	[57]
S17	B. bifidum, intestinal isolate from a breast-fed infant	[57]
E18	B. infantis/longum, intestinal isolate from an adult	[57]
MB226	B. breve, type strain	D. Matteuzzi

¹ DSMZ: Deutsche Sammlung von Mikroorganismen und Zellkulturen; ² NCC: Nestlé Culture Collection.

Citation: Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation. World J Gastroenterol 2006; 12(23): 3729-3735
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3729.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3729